Methoserpidine
Names | |
---|---|
IUPAC name Methyl 10,17α-dimethoxy-18β-[(3,4,5-trimethoxybenzoyl)oxy]-3β,20α-yohimban-16β-carboxylate | |
Systematic IUPAC name Methyl (1S,2R,3R,4aS,13bR,14aS)-2,10-dimethoxy-3-[(3,4,5-trimethoxybenzoyl)oxy]-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2′,3′:3,4]pyrido[1,2-b]isoquinoline-1-carboxylate | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChemSpider |
|
ECHA InfoCard | 100.011.576 |
EC Number |
|
PubChem CID |
|
UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
Properties | |
Chemical formula | C33H40N2O9 |
Molar mass | 608.688 g·mol−1 |
Pharmacology | |
C02AA06 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). N verify (what is YN ?) Infobox references |
Chemical compound
Methoserpidine is an antihypertensive drug related to reserpine.[1]
References
- ^ Jones, D. L.; Michael, A. M.; Ommer, J. P. (1961). "Clinical Trial of Methoserpidine in General Practice". British Medical Journal. 2 (5269): 1738–1741. doi:10.1136/bmj.2.5269.1738. PMC 1970934. PMID 14452236.
- v
- t
- e
(antagonize α-adrenergic
vasoconstriction)
Central |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Peripheral |
|
Serotonin receptor antagonists | |
---|---|
Endothelin receptor antagonists (for PHTooltip Pulmonary hypertension) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e